Rein Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Rein Therapeutics, Inc. (RNTX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 90.67 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-05
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 90.67M shares, a 8.74% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 90.59M shares, a 120.97% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 90.55M shares, a 130.28% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 90.46M shares, a 189.73% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 88.81M shares, a 154.70% increase from fiscal 2020.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 34.87M shares, a 42.11% increase from fiscal 2019.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 24.54M shares, a 66.48% increase from fiscal 2018.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 14.74M shares, a 98.01% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 90.67M shares 10-Q · filed 2022-05-05 | 90.63M shares derived: average of 2 quarters · filed 2022-05-05 | 90.61M shares derived: average of 3 quarters · filed 2022-05-05 | 90.57M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 90.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 90.57M shares derived: average of 2 quarters · filed 2022-03-28 | 90.53M shares derived: average of 3 quarters · filed 2022-03-28 | 88.81M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 90.55M shares 10-Q · filed 2021-11-12 | 90.50M shares derived: average of 2 quarters · filed 2021-11-12 | 88.21M shares 10-Q · filed 2021-11-12 | 76.35M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-06-30 | 90.46M shares 10-Q · filed 2021-08-11 | 86.94M shares 10-Q · filed 2021-08-11 | 71.61M shares derived: average of 3 quarters · filed 2022-05-05 | 63.54M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-03-31 | 83.38M shares 10-Q · filed 2022-05-05 | 62.19M shares derived: average of 2 quarters · filed 2022-05-05 | 54.57M shares derived: average of 3 quarters · filed 2022-05-05 | 48.73M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 41.00M shares 10-K · filed 2021-03-24 | 40.16M shares derived: average of 2 quarters · filed 2021-11-12 | 37.18M shares derived: average of 3 quarters · filed 2021-11-12 | 34.87M shares 10-K · filed 2022-03-28 |
| 2020-09-30 | 39.32M shares 10-Q · filed 2021-11-12 | 35.27M shares derived: average of 2 quarters · filed 2021-11-12 | 32.81M shares 10-Q · filed 2021-11-12 | 31.54M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | 31.22M shares 10-Q · filed 2021-08-11 | 29.52M shares 10-Q · filed 2021-08-11 | 28.95M shares derived: average of 3 quarters · filed 2021-08-11 | 28.66M shares derived: average of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | 27.81M shares 10-Q · filed 2021-05-11 | 27.81M shares derived: average of 2 quarters · filed 2021-05-11 | 27.81M shares derived: average of 3 quarters · filed 2021-05-11 | 27.74M shares derived: average of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | 27.81M shares 10-K · filed 2021-03-24 | 27.81M shares derived: average of 2 quarters · filed 2021-03-24 | 27.72M shares derived: average of 3 quarters · filed 2021-03-24 | 24.54M shares 10-K · filed 2021-03-24 |
| 2019-09-30 | 27.81M shares 10-K · filed 2021-03-24 | 27.67M shares derived: average of 2 quarters · filed 2021-03-24 | 23.43M shares 10-Q · filed 2020-11-12 | 21.22M shares derived: average of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | 27.53M shares 10-K · filed 2021-03-24 | 21.21M shares 10-Q · filed 2020-08-05 | 19.03M shares derived: average of 3 quarters · filed 2021-03-24 | 17.96M shares derived: average of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | 14.82M shares 10-K · filed 2021-03-24 | 14.78M shares derived: average of 2 quarters · filed 2021-03-24 | 14.77M shares derived: average of 3 quarters · filed 2021-03-24 | 14.76M shares derived: average of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | 14.75M shares 10-K · filed 2020-03-30 | 14.74M shares derived: average of 2 quarters · filed 2020-03-30 | 14.74M shares derived: average of 3 quarters · filed 2020-03-30 | 14.74M shares 10-K · filed 2020-03-30 |
| 2018-09-30 | 14.74M shares 10-K · filed 2020-03-30 | 14.74M shares derived: average of 2 quarters · filed 2020-03-30 | 14.74M shares 10-Q · filed 2019-11-07 | 14.73M shares derived: average of 4 quarters · filed 2020-03-30 |
| 2018-06-30 | 14.74M shares 10-K · filed 2020-03-30 | 14.73M shares 10-Q · filed 2019-08-06 | 14.73M shares derived: average of 3 quarters · filed 2020-03-30 | 14.53M shares derived: average of 4 quarters · filed 2020-03-30 |
| 2018-03-31 | 14.73M shares 10-K · filed 2020-03-30 | 14.73M shares derived: average of 2 quarters · filed 2020-03-30 | 14.46M shares derived: average of 3 quarters · filed 2020-03-30 | 10.96M shares derived: average of 4 quarters · filed 2020-03-30 |
| 2017-12-31 | 14.72M shares 10-K · filed 2019-03-29 | 14.33M shares derived: average of 2 quarters · filed 2019-03-29 | 9.70M shares derived: average of 3 quarters · filed 2019-03-29 | 7.44M shares 10-K · filed 2019-03-29 |
| 2017-09-30 | 13.94M shares 10-K · filed 2019-03-29 | 7.20M shares derived: average of 2 quarters · filed 2019-03-29 | 4.99M shares 10-Q · filed 2018-11-07 | 3.81M shares derived: average of 4 quarters · filed 2019-03-29 |
| 2017-06-30 | 450.50K shares 10-K · filed 2019-03-29 | 441.66K shares 10-Q · filed 2018-08-07 | 438.55K shares derived: average of 3 quarters · filed 2019-03-29 | 436.64K shares derived: average of 4 quarters · filed 2019-03-29 |
| 2017-03-31 | 432.73K shares 10-K · filed 2019-03-29 | 432.57K shares derived: average of 2 quarters · filed 2019-03-29 | 432.02K shares derived: average of 3 quarters · filed 2019-03-29 | 431.24K shares derived: average of 4 quarters · filed 2019-03-29 |
| 2016-12-31 | 432.41K shares 10-K · filed 2018-04-02 | 431.67K shares derived: average of 2 quarters · filed 2018-04-02 | 430.74K shares derived: average of 3 quarters · filed 2018-04-02 | 429.69K shares 10-K · filed 2018-04-02 |
| 2016-09-30 | 430.93K shares 10-K · filed 2018-04-02 | 429.90K shares derived: average of 2 quarters · filed 2018-04-02 | 428.77K shares 10-Q · filed 2017-11-09 | |
| 2016-06-30 | 428.87K shares 10-K · filed 2018-04-02 | 427.68K shares 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | 426.49K shares 10-K · filed 2018-04-02 | |||
| 2015-12-31 | 400.71K shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |